These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7721895)

  • 41. JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and betac subunit, respectively, and are activated upon IL-5 stimulation.
    Ogata N; Kouro T; Yamada A; Koike M; Hanai N; Ishikawa T; Takatsu K
    Blood; 1998 Apr; 91(7):2264-71. PubMed ID: 9516124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
    Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
    Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
    Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
    Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
    Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells.
    Huang HM; Lin YL; Chen CH; Chang TW
    J Cell Biochem; 2005 Oct; 96(2):361-75. PubMed ID: 15988755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits.
    Moriggl R; Erhardt I; Kammer W; Berchtold S; Schnarr B; Lischke A; Groner B; Friedrich K
    Eur J Biochem; 1998 Jan; 251(1-2):25-35. PubMed ID: 9492265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
    Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
    J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5.
    Kouro T; Kikuchi Y; Kanazawa H; Hirokawa K; Harada N; Shiiba M; Wakao H; Takaki S; Takatsu K
    Int Immunol; 1996 Feb; 8(2):237-45. PubMed ID: 8671609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7.
    Sharfe N; Roifman CM
    J Immunol; 1997 Aug; 159(3):1107-14. PubMed ID: 9233603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
    Avalos BR; Parker JM; Ware DA; Hunter MG; Sibert KA; Druker BJ
    Exp Hematol; 1997 Feb; 25(2):160-8. PubMed ID: 9015216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.
    Saharinen P; Silvennoinen O
    J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.
    Hornakova T; Staerk J; Royer Y; Flex E; Tartaglia M; Constantinescu SN; Knoops L; Renauld JC
    J Biol Chem; 2009 Mar; 284(11):6773-81. PubMed ID: 19139102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
    Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
    J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physical association of JAK1 and JAK2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains.
    Tanaka N; Asao H; Ohbo K; Ishii N; Takeshita T; Nakamura M; Sasaki H; Sugamura K
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7271-5. PubMed ID: 8041779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unusual interleukin-4 and -13 signaling in human normal and tumor lung fibroblasts.
    Doucet C; Jasmin C; Azzarone B
    Oncogene; 2000 Nov; 19(51):5898-905. PubMed ID: 11127821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
    Wang HY; Zamorano J; Keegan AD
    J Biol Chem; 1998 Apr; 273(16):9898-905. PubMed ID: 9545332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The immunohistochemical localization of signal-transduction pathway components Jak1, Jak2, Jak3, Tyk2 and STAT-1 during early enamel and dentine formation in rat molars.
    Tanase S; Bawden JW
    Arch Oral Biol; 1996 Oct; 41(10):925-40. PubMed ID: 9031700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
    J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.
    Degryse S; de Bock CE; Cox L; Demeyer S; Gielen O; Mentens N; Jacobs K; Geerdens E; Gianfelici V; Hulselmans G; Fiers M; Aerts S; Meijerink JP; Tousseyn T; Cools J
    Blood; 2014 Nov; 124(20):3092-100. PubMed ID: 25193870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.